Abstract
Cancer is an extremely fatal disease, not only in developed but also in developing countries as it affects six million lives each year worldwide. According to the American Cancer Society each year 0.5% of US population is diagnosed with cancer. Annually, billions of dollars are invested on cancer research, yet the success rates are not satisfactory. Cancer cells arise due to the imbalance in the body functions and they invade and infect the normal cells. Cancer is not one disease; rather it is a group of various diseases. The present chapter includes explicit information on cancer types such as cancer of blood, lungs, colon and rectum, prostate, skin, breast, uterus, thyroid, lymphatic system, etc. Cancers are being treated by various methods which include chemotherapy, precision medicine, radiation therapy, surgery, stem cell transplant, hormone therapy, immune therapy, and targeted therapy. In some cases, cancer can be treated by single method, but mostly several methods are used to cure the disease. Moreover, the treatment specifically depends upon the stage and type of cancer. In chemotherapy and radiotherapy, survival rates are usually very low because of their undesirable side effects on human health. On the contrary, herbal therapy alone and in combination with the routine cancer treatment regimes has shown some promising potential, as it is free from side effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas J, Dar WR, Latief M, Farooq S, Parry MA, Ziaulhaq P, Sofi NU, Dar I (2016) Gastrointestinal stromal tumors: a review. J Mol Imag Dynamic 10(4172):2155–9937
Abbasi NR (2008) Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol 144:538–540
Advani P, Paulus A, Ailawadhi S (2019) Updates in prognostication and treatment of Waldenström’s macroglobulinemia. Hematology/oncology and stem cell therapy (in press)
Aggarwal A, Lewison G, Idir S, Peters M, Aldige C, Boerckel W, Boyle P, Trimble EL, Roe P, Sethi T, Fox J, Sullivan R (2016) The state of lung cancer research: a global analysis. J Thorac Oncol 11(7):1040–1050
Albers P, Albrecht W, Algaba F (2015) Guidelines on testicular cancer: 2015 update. Eur Urol 68(6):1054–1068
Ali MZ, Sultana S (2012) Blood cancer. Bangladesh Research Institute 221:4303–4602
Ali I, Wani WA, Saleem K (2011) Cancer scenario in India with future perspectives. Cancer Ther 8:56–70
American Cancer Society. (2015) Cancer facts and figures
American Cancer Society, 2017, USA
Anjum F, Ravi N, Msood MA (2017) Breast cancer therapy: a mini review. MOJ Drug Des Dev Ther 1(2):00006
Babjuk M, Böhle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461
Banumathy G, Cairns P (2010) Signaling pathways in renal cell carcinoma. Cancer Biol Ther 10:658–664
Bãrbuş E, Peştean C, Larg MI, Piciu D (2017) Quality of life in thyroid cancer patients: a literature review. Clujul Med 90(2):147–153
Bermick (2008) Are tanning beds “safe”. Human studies of melanoma. Pigment Cell Melanoma Res 21(5):517–519
Blackadar CB (2016) Historical review of the causes of cancer. World J Clin Oncol 7(1):54–86
Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559–1564
Chng WJ, Glebov O, Bergsagel PL (2007) Genetic events in the pathogenesis of multiple myeloma. Best Pract Res Clin Haemotal 20(4):571–596
Chou J, Lin Y, Kim J, You L, Xu Z (2017) Nasopharyngeal carcinoma– a review of the molecular mechanisms of tumorigenesis. Head Neck 30(7):946–963
Coimbra S, Neves R, Lima M, Belo L, Silva AS (2014) Waldenstrom’s macroglobulinemia review. Rev Assoc Med Bras 60(5):490–499
Cserni G, Chmielik E, Cserni B, Tot T (2018) The new TNM-based staging of breast cancer. Virchows Arch 472(5):697–703
Finicle BT, Jayashankar V, Edinger AL (2018) Nutrient scavenging in cancer. Nat Rev Cancer 18:619–633
Flis S, Chojnacki T (2019) Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities. Drug Des Devel Ther 13:825–843
Fu JH, Rong TH, Li XD, Hu V, Ou W, Hu YH, Li Q (2004) Chemotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial. Ai Zheng 23(11):1473–1476
Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphogenic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663
Gandaglia G, Ravi P, Abdollah F, Abd-El-Barr AE, Becker A, Popa I, Briganti A, Karakiewicz PI, Trinh QD, Jewett MA, Sun M (2014) Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J 8:247–252
Gertz MA (2019) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 94(2):266–276
GLOBOCAN (2012) v1.0, cancer incidence and mortality worldwide: IARC Cancer Base no. 11. International Agency for Research on Cancer Web site. http://globocan.iarc.f
Goblirsch MJ, Zwolak PP, Clohisy DR (2006) Biology of bone Cancer pain. Clin Cancer Res 12:6231s–6235s
Gogoi G, Borgohain M, Saikia P, Patel B, Hazauka RK, Brahma RC, Gogoi B, Saikia N, Rabha J (2017) Histomorphological study of soft tissue tumours and review of literature of rarer types. Int Clin Pathol J 4:00113–00123
Gubbels JAA, Claussen N, Kapur AK, Connor JP, Patankar MS (2010) The detection, treatment and biology of epithelial ovarian cancer. J Ovarian Res 3(8):1757–2215
Hartman RI, Lin JY (2019) Cutaneous melanoma-a review in detection, staging, and management. Hematol Oncol Clin North Am 33(1):25–38
Heitz APM, Odicino F, Maisonneuva P, Quinn MA, Benedet JL, Creasmam WT, Ngan HYS, Pecorelli S, Beller U (2006) Carcinoma of the ovary. Intituto Europeo di Oncologia 95(1):60033–60037
Hoang NT, Acevedo LA, Mann MJ, Tolani B (2018) A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res 10:1089–1114
Huang S (2018) Physical activity and risk of testicular cancer-a systematic review. BMC Cancer 18(1):189
Ivanyi P, Fuehner T, Adam M, Eichelberg C, Herrmann E, Merseburger AS, Ganser A, Grunwald V (2014) Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres. Med Oncol 31:147
Jabbour E, Kantarjian H (2018) Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol 93:442–459
Jaggi P (2017) A review article on lung cancer diagnosis and treatment. JMAHS 6(1):2318–9865
Jarmusch AK, Pirro V, Baird Z, Hattab EM, Cooks G (2016) Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization. MS PNAS 113(6):1486–1419
Kamoun W, Elden S, Christine P, Lia L, Jason C, Irawati K, Richard H (2018) Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic. Am Assoc Cancer Res 78(13):5771–5771
Karst AM, Drapkin R (2010) Ovarian cancer pathogenesis: a model of evolution. J Oncol 10:93237
Kato T, Inoue H, Imoto S, Tamada Y, Miyamoto T, Matsuo Y, Nakamura Y, Park JH (2016) Oncogenic roles of TOPK and MELK and effective growth suppression by small molecular inhibitors in kidney cancer cells. Oncotarget 7(14):17652
Khaider NG, Lane D, Matte I, Rancourt C, Piche A (2011) Targeted ovarian cancer treatment: the TRAILs of resistance. AMJ Cancer Res 2(1):75–92
Kirkali Z, Canda AE (2008) Open partial nephrectomy in the management of small renal masses. Adv Urol 309760
Kirkali Z, Tuzel E, Mungan MU (2001) Recent advances in kidney cancer and metastatic disease. BJU Int 88(8):818–824
Kotz R, Dominkus M, Zettl T, Ritschl P, Windhager R, Gadner H, Zielinski C, Salzer-Kuntschik M (2002) Advances in bone tumour treatment in 30 years with respect to survival and limb salvage. A single institution experience. Int Orthop 26(4):197–202
Lai JS, Beaumont JL, Diaz J, Khan S, Cella D (2016) Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinoma. Cancer 122:287–295
Laura H (2016) Hodgkin’s disease and lymphoma. Am Cancer Soc 32(7):34–42
Laws ER Jr, Thapar K (1993) Brain tumors. CA Cancer J Clin 43:263–271
Layke JC, Lopez PP (2006) Esophageal cancer: a review and update. Am Fam Physician 73:2187–2194
Leitzmann MF, Rohrmann S (2012) Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol 4:1–11
Lin JS, Bowles EJ, Williams SB, Morrison CC (2017) Screening for thyroid cancer: updated evidence report and systematic review for the US preventive services task force. JAMA 31:888–903
Ljungberg B, Bensalah K, Bex A et al (2014) Guidelines on renal cell carcinoma. European Association of Urology. Available at https://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_2017_web.pdf
Lorsbach RB, His ED, Dogan A, Fend F (2011) Plasma cell myeloma and related neoplasm. Am J Clin Pathol 136(2):168–182
Luger NM, Honore P, Sabino MA, Schwei MJ, Rogers SD, Mach DB, Clohisy DR, Mantyh PW (2001) Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res 61(10):4038–4047
Magalhaes KCS, Vaz JPM, Gontijo PAM, Carvalho GTC, Christo PP, Simoes RT, Silva KR (2016) Profile of patients with brain tumors and tumors and the role of nursing care. Rev Bras Enferm 69(1):138–143
Maguire R, Andelkovic V, Chauhan H, Nolan GJ (2017) Advances in the management of soft tissue sarcomas- focus on emerging therapies. Clin Oncol 2:1189–1196
Marnouche E (2017) Diagnosis, therapeutic and evolutionary characteristics of nasopharyngeal Cancer in Morocco. J Cancer Sci Ther 9:439–444
Martínez-Carmona M, Lozano D, Baeza A, Colilla M, Vallet-Regí M (2018) A novel visible light responsive nanosystem for cancer treatment. Nanoscale 9(41):15967–15973
Miranda MB, Leusekes M, Kraus MP, Hanftein B, Fabarin A, BAerloches GM (2016) Secondary malignancies in chronic myeloid leukemia patients after imatinib based treatment: long term observation. Leukemia 30(6):1255–1262
Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K (2006) Diagnosis of pancreatic cancer. HPB (Oxford) 8(5):337–342
Moore K, Kim L (2010) Primary brain tumors: characteristics practical diagnostic and treatment approaches. Molecular mechanism of pathogenesis and current therapeutic strategies 10:42–75
Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, Santis MD, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629
Muglia VF, Prando A (2015) Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras 48(3):166–174
National Comprehensive Cancer Network. Guidelines for patients version 1, 2016
National Comprehensive Cancer Network. Guidelines for patients 2017
Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, Cosciani Cunico S, Imbimbo C, Longo N, Martignoni G, Martorana G, Minervini A, Mirone V (2010) Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58:588–595
Paek SC (2008) Cutaneous melanomas. Fitzpatrick’s Dermatology in General Medicine 109(1):100–108
Paladini A, Boni A, Quadrini F, Cochetti G, Mearini E (2017) First report of simultaneous robotic treatment of kidney cancer and enucleation of pancreatic metastasis. Eur Uro 16(6):2385
Patil M, Prabhu S, Patil S, Patil S (2013) Brain tumor identification using K–means clustering. IJETT 4(3):354–357
Permutt WJ, Sellers TA (2009) Epidemiology of ovarian cancer. Methods Mol Biol 472:413–437
Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Rehak P, Pummer K, Zigeuner R (2011) External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol 186:1773–1777
Pokharel M (2012) Leukemia a review article. Leukemia IJARP 2(3):397–407
Reck M, Rabe KF (2017) Precision diagnosis and treatment for advanced non–small cell lung cancer. N Engl J Med 377:849–861
Roett MA, Evans P (2009) Ovarian cancer: an overview. Am Fam Physician 80(6):609–616
Salati SA, Al Kadi A (2012) Anal cancer. Int J Cancer Health Sci 6(2):206–230
Schmidbauer B, Menhart K, Hellwig D, Grosse J (2017) Differentiated thyroid Cancer-treatment: state of the art. Int J Mol Sci 18(6):1292
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66:7–30
Son SH, Song JH, Choi BO et al (2012) The technical feasibility of an image-guided intensity-modulated radiotherapy (IGIMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer. Radiat Oncol 7, Article 203
Stolzoff M, Webster TJ (2016) Reducing bone cancer cell functions using selenium nanocomposites. J Biomed Mater Res 104:476–482
Suttle AB, Ball HA, Molimard M, Hutson TE, Carpenter C, Rajagopalan D, Lin Y, Swann S, Amado R, Pandite L (2014) Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma. Br J Cancer 111:1909–1916
Wan J, Li XM, Gu J (2014) Primary Choriocarcinoma of the fallopian tube: a case report and literature review. Eur J Gynaecol Oncol 35(5):604–607
Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW (2001) Ultraviolet a and melanoma: a review. J Am Acad Dermatol 44:837–846
Weinberg RA (2014) The biology of cancer, 2nd edn
Willemsen AE, Grutters JC, Gerritsen WR, van Erp NP, van Herpen CM, Tol J (2016) mTOR inhibitor-induced interstitial lung disease in cancer patients: comprehensive review and a practical management algorithm. Int J Cancer 138:2312–2321
Winkler T, Sass FA, Duda GN, Schmidt-Bleek K (2018) A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering: the unsolved challenge. Bone Joint Res 7(3):232–243
Wong R, Malthaner R (2006) Combined chemotherapy and radiotherapy. Cochrane Database Syst Rev 1:CD002092
Wuellner L (2014) Understanding brain tumours. Cancer Council NSW 54(12):134–164
www.cancer.net (2017)
www.cancer.org National Cancer Institute, 2018
Yamamoto E (2009) Ovary: choriocarcinoma. Atlas genet. Cytogenet Oncol Haematol 13(9):683–685
Yaxley JP (2016) Bladder cancer. J Family Med Prim Care 5(3):533–538
Yeole BB (2008) Trends in the brain cancer incidence in India. Asian Pac J Cancer Prev 9(2):267–270
Yoo KY, Shin HR (2003) Cancer epidemiology and prevention. Korean J Epidemiol 25:1–15
Zotos D, Taclinton D (2012) Determining B-cell fate. Trends Immunol 33(6):280–288
Zujewski JA, Harlan LC, Morrell DM, Stevens JL (2011) Ductal carcinoma in situ: trends in treatment over time in the US. Breast Cancer Res Treat 127(1):251–257
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Koul, B. (2019). Types of Cancer. In: Herbs for Cancer Treatment. Springer, Singapore. https://doi.org/10.1007/978-981-32-9147-8_2
Download citation
DOI: https://doi.org/10.1007/978-981-32-9147-8_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9146-1
Online ISBN: 978-981-32-9147-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)